I currently work for a Point of Care medical device company. My company focuses on the hand held type instead of the larger models. Based on my understanding of the market, PoCT is slow to launch new test types because the amount of overhead and the new product would have to offer substantially different capabilities than what is on the current market. However, I do understand there is future direction in the field to make products that will test for infectious disease. This product would need to be extremely sensitive molecular techniques and would be marketable in both the developed and developing world. Additionally, there is also interest in other clinical applications such as diagnosing traumatic brain injury.